I disse studier blev 236 patienter behandlet med Xeloda (1250 mg/ m2 to gange dagligt i 2 uger efterfulgt af en uges pause).
In these trials, a total of 236 patients were treated with Xeloda (1250 mg/ m2 twice daily for 2 weeks followed by 1-week rest period).